"Concepts and Breakthroughs in Glaucoma" Conference

“青光眼的概念与突破”会议

• 批准号: 10317233
• 负责人: W Daniel Stamer
• 金额: $ 2.71万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-01 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10317233
• 关键词: Academia; Advanced Development; Area; Award; Back; Basic Science; Blindness; Cellular biology; Clinical; Clinical Research; Collaborations; Country; Development; Diagnosis; Disease; Disease Progression; Environment; Eye; Feedback; Fellowship; Fostering; Foundations; Functional disorder; Funding; Future; Glaucoma; Goals; Homeostasis; Individual; Industry; Institution; International; Learning; Location; Mentorship; Mind; Molecular; Monitor; Morehouse School of Medicine; Natural regeneration; Ophthalmologist; Optic Disk; Participant; Pathogenesis; Pathology; Patient Care; Patients; Physiologic Intraocular Pressure; Public Health; Recording of previous events; Research; Research Personnel; Reservations; Resources; Retinal Ganglion Cells; Scientist; Secure; Senior Scientist; Series; Societies; Structure; Students; Tissues; Translating; Translational Research; Translations; Travel; Underrepresented Populations; Universities; Vision; Woman; Work; career; career development; cell injury; educational atmosphere; ethnic diversity; imaging modality; interest; lectures; meetings; member; neuroprotection; new technology; novel; novel therapeutics; posters; recruit; role model; symposium; translational impact

Summary This proposal seeks support for students and junior investigators (travel awardees) to attend the 2021 Inter- national Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Concepts and Breakthroughs in Glaucoma" to be held October 6th-9th, 2021 in Atlanta, Georgia at the Emory Conference Center and Hotel. As was the case for the 2017 and 2019 meetings, our goal is to bring together basic scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on recent excit- ing research advances and developments in molecular mechanisms underlying glaucomatous pathology, in both the conventional outflow tract and the optic nerve head. Additionally, novel technologies developed: (i) to diagnose and monitor disease progression, (ii) to modify/restore glaucomatous dysfunction, and (iii) to regen- erate damaged cells/tissues will be presented. We have already recruited 5 thought leaders in glaucoma to give keynote lectures at the conference. As with the 2017 and 2019 meetings, the platform sessions will be selected exclusively from submitted abstracts. We have reserved one platform session for travel awardees and we are again putting on a one-day "crash course" in glaucoma for people new to glaucoma and stu- dents/junior investigators, consistent with our goal of increasing participation of young scientists. ISER and BFF have an established history of promoting diversity, and the selected speakers (from abstracts) will repre- sent a diverse group of scientists that includes women and members of historically underrepresented groups. The Specific Aims of the conference are to: 1. Enhance the emerging careers of at least 30 young investigators working in glaucoma research, including women and members of underrepresented groups, by providing travel awards. 2. Provide a forum for the dissemination of the most recent advances in glaucoma research. 3. Create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists, and which will generate the opportunity for vision scientists with diverse personal and scientific back- grounds to meet and establish research collaborations. 4. Bring together scientists working in disparate areas of glaucoma research. We anticipate that this meeting will provide state-of-the-art information on recent advances in glaucoma and will serve as an important resource for those involved in the translation of these findings into novel therapeu- tics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 18 students (pre- and postdoctoral) and 12 junior investigators who otherwise would not have the resources to attend this focused meeting.

概括 该提案寻求支持学生和初级调查人员（旅行获奖者）参加2021年间 国家眼睛研究学会（ISER） - 布赖特焦点基金会（BFF）青光眼会议标题为“概念 以及将于2021年10月6日至9日在佐治亚州亚特兰大举行的埃默里会议上，将于10月6日至9日在埃默里会议上举行 中心和酒店。与2017年和2019年会议一样，我们的目标是结合基本 科学家，临床医生科学家，学生和研究员进行演讲和深入讨论，以讨论最近的兴奋 研究的研究和发展是在青光眼病理基础的分子机制方面的发展， 常规流出道和视神经头。此外，开发了新技术：（i） 诊断和监测疾病的进展，（ii）修改/恢复青光眼功能障碍，以及（iii）再生 将提出损坏的细胞/组织。我们已经招募了5位青光眼的思想领袖到 在会议上进行主题演讲。与2017年和2019年会议一样，平台会议将是 专门从提交的摘要中选择。我们为旅行奖励者保留了一个平台会议 而且，我们再次为青光眼的青光眼上的一日“速成课程”，用于青光眼和Stu的新人 凹痕/初级调查人员，与我们增加年轻科学家参与的目标一致。 iser和 BFF具有促进多样性的既定历史，选定的演讲者（来自摘要）将获得 派出了包括妇女在内的一系列科学家和历史上代表性不足的群体的成员。 会议的具体目的是： 1。提高至少30名青光眼研究的年轻研究人员的新兴职业，包括 妇女和代表性不足的团体成员通过提供旅行奖。 2。提供一个论坛，以传播青光眼研究的最新进展。 3。创建一个环境，可以促进基础和临床科学家之间的新思想交流， 这将为具有多样化的个人和科学背面的视力科学家带来机会 - 建立和建立研究合作的理由。 4。将在青光眼研究不同领域工作的科学家聚集在一起。 我们预计这次会议将提供有关青光眼和青光眼最新进展的最新信息 对于参与这些发现转化为新颖疗法的人来说，将是一个重要资源 抽动。这次会议还将提供新的机会，新发现的途径，以及一个发展论坛 与会者之间的潜在合作。要求的资金将支持旅行，住宿 以及18名学生（博士后和博士后）和12名初级调查人员的注册 有资源参加这次重点会议。